U.S. Paper and Forestry Products Stock News

A law firm has opened an investigation into McKesson's Board of Directors over potential breaches of fiduciary duty tied to a 2013 stock incentive plan. The review focuses on the Board's recommendation that shareholders approve issuing a substantial number of additional shares and the possible dilutive effect on existing holders. The inquiry centers on whether the Board acted in the best interests of shareholders when it supported the expanded stock issuance. For investors in McKesson,...

Recent performance snapshot With no single headline event setting the tone, Mueller Water Products (MWA) has drawn attention through its recent share performance and financial profile, prompting investors to reassess how this water infrastructure supplier fits into their portfolios. The stock last closed at $29.92, with reported total returns of 1.1% over the past day and a small decline over the past week. Over the past month and past 3 months, returns are in double digits, and the reported...

Iovance Biotherapeutics (IOVA) closed out FY 2025 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.18, alongside a quarterly net loss of US$71.9 million. The company has seen quarterly revenue move from US$73.7 million in Q4 2024 to US$86.8 million in Q4 2025, while basic EPS shifted from a loss of US$0.26 to a loss of US$0.18 over the same period, setting up a results season where investors are weighing growing sales against ongoing losses. With trailing twelve...

Rackspace Technology (RXT) has quickly moved onto many investors’ radars after announcing a partnership with Palantir Technologies that positions the company as a managed services provider for Palantir’s data and AI platforms. See our latest analysis for Rackspace Technology. The Palantir announcement has coincided with a sharp shift in sentiment, with a 7 day share price return of 248.45% and a 30 day share price return of 82.07%. However, the 1 year total shareholder return of 43.41% and 5...

In February 2026, Clean Energy Fuels reported fourth-quarter 2025 results showing revenue of US$112.32 million and a wider net loss of US$43.00 million, alongside guidance for a 2026 net loss attributable to the company of US$71.00 million to US$66.00 million, excluding unrealized contract impacts and estimated US$47.00 million of Amazon warrant charges. The company also flagged that swings in diesel and natural gas markets, plus variations in Amazon warrant vesting, could materially alter...

What the Hiab dealer agreement could mean for Custom Truck One Source (CTOS) Hiab’s new dealer agreement with Custom Truck One Source (CTOS) expands sales and service coverage for HIAB loader cranes and MOFFETT truck mounted forklifts across multiple US states, giving CTOS broader access to equipment customers. See our latest analysis for Custom Truck One Source. The Hiab deal lands at a time when momentum in Custom Truck One Source’s share price has been building, with a 30 day share price...

If you are wondering whether Venture Global's share price is offering value right now, you are not alone. This article is set up to help you frame that question clearly. The stock last closed at US$9.35, with a 6.6% gain over the past 7 days, a 5.4% decline over 30 days, a 32.8% return year to date, and a 33.3% decline over the last year. Recent coverage around Venture Global has focused on its position in the US energy market and ongoing interest in liquefied natural gas projects, which...

Recent industry reports highlight strong past and projected growth in flexible packaging, emphasizing rising demand for lightweight, sustainable solutions across food, pharmaceutical, and e-commerce applications, with Amcor frequently cited as a key innovator in this space. In parallel, the US nutraceutical packaging market is expected to expand from about US$1.54 billion in 2025 to roughly US$2.12 billion by 2033, underlining a growing opportunity for Amcor in higher-value, safety-focused...

What recent performance says about Interparfums (IPAR) Interparfums (IPAR) has drawn fresh attention after a period of mixed share performance, with gains over the past month and past 3 months alongside weaker one year and three year total returns. For investors tracking shorter time frames, the stock shows a month return of 4.3% and a past 3 months return of 27.2%, compared with a year to date gain of 20.5%. Over longer horizons, the one year total return stands at a 23.8% decline, while the...

Lindsay (NYSE:LNN) has introduced two new safety products, the Road Runner Truck-Mounted Attenuator and the AlphaGuard Channelizing Device. The products expand the company’s roadway and work zone safety lineup, targeting construction and traffic management applications. Both launches focus on work zone protection, operational efficiency, and evolving infrastructure management needs. Lindsay, trading at $135.74, is building on its position in roadway and infrastructure safety with these new...

If you are wondering whether Fidelity National Financial is priced fairly today, you are not alone. The stock sits at the center of some interesting valuation questions that are worth unpacking. The share price closed at US$51.94, with returns of a 9.6% decline over 7 days, a 2.8% decline over 30 days, a 4.3% decline year to date, but gains of 8.5% over 1 year, 52.0% over 3 years, and 73.4% over 5 years. Recent price moves have come alongside ongoing attention on the broader title insurance...

ImmunityBio FY 2025 earnings snapshot ImmunityBio (IBRX) has reported its FY 2025 results with Q4 revenue of US$38.3 million and a basic EPS loss of US$0.06, alongside net income loss excluding extra items of US$61.9 million. This puts the focus squarely on how quickly the business can scale to cover its cost base. The company has seen quarterly revenue move from US$7.6 million in Q4 2024 to US$16.5 million in Q1 2025, US$26.4 million in Q2 2025, US$32.1 million in Q3 2025 and US$38.3 million...

If you are wondering whether Invitation Homes is starting to look like value at its current share price, this article will walk through what the numbers actually say about that question. The stock closed at US$25.67, with returns of 5.4% decline over 7 days, 5.6% decline over 30 days, 7.4% decline year to date, 16.9% decline over 1 year, 9.0% decline over 3 years and 1.6% gain over 5 years. These figures may have some investors reassessing both the potential upside and the risks. Recent...

If you are wondering whether Ionis Pharmaceuticals' share price still reflects good value after a strong run, this article walks through what the current market price might be implying. The stock most recently closed at US$85.45, with returns of 5.0% over 7 days, 6.4% over 30 days, 7.3% year to date, 168.3% over 1 year, 138.0% over 3 years and 54.5% over 5 years, which naturally raises questions about future risk and reward. Recent news flow around Ionis has continued to focus on its role in...

Buyback completions put DaVita’s capital return in focus DaVita (DVA) has just wrapped up two sizeable share repurchase authorizations, a move that is drawing fresh attention to how the kidney care provider is using its balance sheet to return cash to shareholders. See our latest analysis for DaVita. At a share price of $150.91, DaVita’s recent buyback completions sit alongside a 30 day share price return of 39.58% and a three year total shareholder return of 83.45%. This suggests that...

In February 2026, Expro Group Holdings reported its fourth-quarter and full-year 2025 results, issued 2026 revenue guidance of US$360 million–US$370 million for the first quarter and US$1.60 billion–US$1.65 billion for the year, and authorized a new share repurchase program of up to US$100 million through December 31, 2026. Alongside steady full-year earnings and a 22% adjusted EBITDA margin in the fourth quarter, Expro highlighted a US$2.50 billion backlog that enhances revenue visibility...

If you are wondering whether PicS is attractively priced at its recent levels, this article will walk through what the current numbers are really saying about the stock. The share price recently closed at US$16.81, with a 7 day return of 27.4% and a year to date return of an 11.5% decline. This has caught the attention of investors who are considering the balance between growth potential and risk. Recent news coverage around PicS has focused on its positioning within the diversified...

Pamela Seymon and former CEO Sharmistha Dubey plan to leave Match Group's Board at the 2026 Annual Meeting. The departures will change the board composition at NasdaqGS:MTCH and affect its governance structure. Investors are watching for how these board changes may influence oversight and long term company direction. Match Group, the parent of several online dating platforms, sits at the center of how people form relationships through digital services. As user behavior, regulation, and...

Martin Marietta Materials (NYSE:MLM) has closed an asset exchange with Quikrete Holdings involving aggregates, cement, ready-mix, and nonoperating land assets. The deal shifts NYSE:MLM further toward an aggregates-led product mix and adds cash to the balance sheet. The transaction covers operations in multiple regions and is described by the company as a key part of its SOAR 2025 plan. Management frames the exchange as a step toward greater earnings durability, added financial flexibility,...

If you are wondering whether IMAX shares still offer value after a strong run, this article walks through what the current price may be implying about the business. The stock closed at US$36.83, with a 7 day return of a 2.7% decline, a 30 day return of 6.4%, a year to date return of 2.2%, and a 1 year return of 39.6%, alongside a 3 year return of 99.7% and a 5 year return of 71.6%. These moves sit against a backdrop of ongoing interest in large format cinema and premium theatrical...

If you are wondering whether Five9 is now a bargain or still carries more risk than reward, looking closely at how its current share price stacks up against different valuation measures can help clarify the picture. The stock last closed at US$17.83, with a 9.2% return over the past week, but returns of 2.7% decline over 30 days, 5.2% decline year to date, and 54.0% decline over the past year, and 73.0% and 90.5% declines over the past 3 and 5 years respectively, highlight how sentiment has...

If you are wondering whether AppFolio's current share price lines up with its underlying value, you are not alone. This article is designed to help you frame that question clearly. The stock closed at US$166.26, with returns of a 1.5% decline over 7 days, a 24.2% decline over 30 days, a 27.8% decline year to date, and a 21.3% decline over 1 year, while the 3 year and 5 year returns sit at 25.9% and 23.3% respectively. These figures can change how investors think about both upside potential...

In the past week, U-Haul Holding Company reported its 3Q FY2026 results, with total revenues rising 1.9% as self-storage revenue increased 7.9%, while higher depreciation and losses on retired rental equipment, particularly cargo vans, reduced earnings per share by US$0.24. An important takeaway is management’s plan to cut more than US$500,000,000 in truck purchases for fiscal 2027 and expand its dealer network to address fleet imbalances and sharpen the core moving and storage...

If you are wondering whether Medpace Holdings at around US$442 per share still offers value, you are not alone, especially after its strong multi year share price performance. The stock is up 3.3% over the last week, even after a 24.8% decline over the past month and a 22.6% decline year to date, set against a 29.7% return over 1 year and 128.1% and 167.7% returns over 3 and 5 years respectively. Recent coverage of Medpace has focused on its role as a contract research organization in...